Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling.

@article{Patsatzis2021AlgorithmicAA,
  title={Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling.},
  author={Dimitrios G. Patsatzis},
  journal={Journal of theoretical biology},
  year={2021},
  pages={
          110975
        }
}

Figures and Tables from this paper

From immune equilibrium to immunodynamics

The traditional theory of immune equilibrium has been mathematized and transformed from a philosophical category into a new concrete scientific theory, namely the theory of immunodynamics, which solves the dilemma that the traditional theory cannot guide individualized medical practice for a long time.

Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human

Algorithmic asymptotic analysis of multi-scale pharmacokinetics (PK) systems can provide system level understanding and predictions on the response of the model when parameters vary and can be used to engineer antibodies with desired PK properties.

References

SHOWING 1-10 OF 85 REFERENCES

Quasi steady state and partial equilibrium approximations: their relation and their validity

The quasi steady state and partial equilibrium approximations are analysed in the context of a system of nonlinear differential equations exhibiting multiscale behaviour. Considering systems in the

A mathematical model for pancreatic cancer growth and treatments.

Computational singular perturbation analysis of brain lactate metabolism

It is shown that a decisive factor on whether the ANLS or NALS configuration will develop during neuronal activation is whether the lactate transport between astrocytes and interstitium contributes to the fast dynamics or not.

Integrative Approaches to Cancer Immunotherapy.

A new Michaelis-Menten equation valid everywhere multi-scale dynamics prevails.

Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology

This mini-review focuses on the evolution and state-of-the-art of quantitative systems models describing the tumor vs. immune system interplay, and their merging with quantitative pharmacology models of IO-modulating agents, as companion tools to support the addressing of these challenges.
...